Davenport & CO LLC Bio Xcel Therapeutics, Inc. Put Options Transaction History
Davenport & CO LLC
- $16.7 Billion
- Q4 2024
Put Options
1 transactions
Others Institutions Holding BTAI
# of Institutions
51Shares Held
3.11MCall Options Held
22.2KPut Options Held
40.2K-
Vanguard Group Inc Valley Forge, PA1.2MShares$372,4260.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$136,6120.0% of portfolio
-
Geode Capital Management, LLC Boston, MA298KShares$92,3930.0% of portfolio
-
Wells Fargo & Company San Francisco, CA185KShares$57,3670.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny130KShares$40,2590.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $8.69M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...